Cerevel Therapeutics Holdings Stock Current Ratio
| CERE Stock | USD 42.24 0.18 0.43% |
Cerevel Therapeutics Holdings fundamentals help investors to digest information that contributes to Cerevel Therapeutics' financial success or failures. It also enables traders to predict the movement of Cerevel Stock. The fundamental analysis module provides a way to measure Cerevel Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cerevel Therapeutics stock.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 10.92 | 7.23 |
Cerevel | Current Ratio |
Cerevel Therapeutics Holdings Company Current Ratio Analysis
Cerevel Therapeutics' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Cerevel Therapeutics Current Ratio | 9.52 X |
Most of Cerevel Therapeutics' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cerevel Therapeutics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cerevel Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Cerevel Therapeutics is extremely important. It helps to project a fair market value of Cerevel Stock properly, considering its historical fundamentals such as Current Ratio. Since Cerevel Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cerevel Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cerevel Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Cerevel Current Ratio Historical Pattern
Today, most investors in Cerevel Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cerevel Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Cerevel Therapeutics current ratio as a starting point in their analysis.
Cerevel Therapeutics Current Ratio |
| Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
Cerevel Price To Sales Ratio
Price To Sales Ratio |
|
In accordance with the recently published financial statements, Cerevel Therapeutics Holdings has a Current Ratio of 9.52 times. This is 227.15% higher than that of the Biotechnology sector and 36.0% higher than that of the Health Care industry. The current ratio for all United States stocks is notably lower than that of the firm.
Cerevel Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cerevel Therapeutics' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cerevel Therapeutics could also be used in its relative valuation, which is a method of valuing Cerevel Therapeutics by comparing valuation metrics of similar companies.Cerevel Therapeutics is currently under evaluation in current ratio category among related companies.
Cerevel Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Cerevel Therapeutics from analyzing Cerevel Therapeutics' financial statements. These drivers represent accounts that assess Cerevel Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cerevel Therapeutics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.5B | 1.2B | 4.4B | 4.8B | 4.3B | 4.5B |
Cerevel Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cerevel Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cerevel Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Cerevel Fundamentals
| Return On Equity | -0.92 | ||||
| Return On Asset | -0.3 | ||||
| Current Valuation | 7.32 B | ||||
| Shares Outstanding | 182.2 M | ||||
| Shares Owned By Insiders | 15.27 % | ||||
| Shares Owned By Institutions | 86.26 % | ||||
| Number Of Shares Shorted | 6.6 M | ||||
| Price To Earning | (0.26) X | ||||
| Price To Book | 11.28 X | ||||
| EBITDA | (441.64 M) | ||||
| Net Income | (432.84 M) | ||||
| Cash And Equivalents | 531.21 M | ||||
| Cash Per Share | 3.58 X | ||||
| Total Debt | 480.78 M | ||||
| Debt To Equity | 0.20 % | ||||
| Current Ratio | 9.52 X | ||||
| Book Value Per Share | 3.10 X | ||||
| Cash Flow From Operations | (342.3 M) | ||||
| Short Ratio | 6.07 X | ||||
| Earnings Per Share | (2.73) X | ||||
| Target Price | 43.4 | ||||
| Number Of Employees | 355 | ||||
| Beta | 1.47 | ||||
| Market Capitalization | 7.69 B | ||||
| Total Asset | 1.24 B | ||||
| Retained Earnings | (1.4 B) | ||||
| Working Capital | 914.76 M | ||||
| Current Asset | 9.77 M | ||||
| Current Liabilities | 5.22 M | ||||
| Net Asset | 1.24 B |
About Cerevel Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cerevel Therapeutics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cerevel Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cerevel Therapeutics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cerevel Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cerevel Therapeutics' short interest history, or implied volatility extrapolated from Cerevel Therapeutics options trading.
Pair Trading with Cerevel Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cerevel Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerevel Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Cerevel Stock
| 0.59 | ZVSA | ZyVersa Therapeutics | PairCorr |
The ability to find closely correlated positions to Cerevel Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cerevel Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cerevel Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cerevel Therapeutics Holdings to buy it.
The correlation of Cerevel Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cerevel Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cerevel Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cerevel Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Cerevel Therapeutics Piotroski F Score and Cerevel Therapeutics Altman Z Score analysis. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Cerevel Stock analysis
When running Cerevel Therapeutics' price analysis, check to measure Cerevel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cerevel Therapeutics is operating at the current time. Most of Cerevel Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cerevel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cerevel Therapeutics' price. Additionally, you may evaluate how the addition of Cerevel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Cerevel Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cerevel Therapeutics. If investors know Cerevel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cerevel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.73) | Return On Assets (0.30) | Return On Equity (0.92) |
The market value of Cerevel Therapeutics is measured differently than its book value, which is the value of Cerevel that is recorded on the company's balance sheet. Investors also form their own opinion of Cerevel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cerevel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cerevel Therapeutics' market value can be influenced by many factors that don't directly affect Cerevel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cerevel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cerevel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cerevel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.